A novel gross deletion and breakpoint junction sequence analysis of ATP7B in a Chinese family with Wilson disease using next‑generation sequencing and Sanger sequencing

Liu,Wei‑Liang; Li,Fang; Liu,Lu; Chen,Wei; He,Zhi‑Xu; Gu,Hao; Ai,Rong

doi:10.3892/mmr.2019.10830

A novel gross deletion and breakpoint junction sequence analysis of ATP7B in a Chinese family with Wilson disease using next‑generation sequencing and Sanger sequencing

Authors:
- Wei‑Liang Liu
- Fang Li
- Lu Liu
- Wei Chen
- Zhi‑Xu He
- Hao Gu
- Rong Ai
View Affiliations

Affiliations: Department of Pediatrics, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China, Department of Ophthalmology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China
Published online on: November 20, 2019 https://doi.org/10.3892/mmr.2019.10830
Pages: 517-523
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Wilson disease (WD) is a rare autosomal recessive genetic disorder that causes abnormal copper metabolism, resulting in pathological accumulation of copper in the liver, brain and other organs. Mutations in the ATPase copper transporter 7B (ATP7B) gene, which encodes a membrane P‑type adenosine triphosphatase, have been identified as being responsible for WD. The present study analyzed clinical data and collected DNA samples from a pediatric patient with WD and her healthy parents. Mutation screening for ATP7B was performed using direct sequencing, multiplex ligation‑dependent probe amplification(MLPA), next‑generation sequencing (NGS) and Sanger sequencing of the breakpoint junction sequence. The patient (age, 2.7 years) presented with early‑onset hepatic disease. The present study identified compound heterozygous mutations of ATP7B, including a heterozygous mutation (p.Arg1,041Trp) and a novel heterozygous gross deletion of a 57,771 bp fragment (chr13: 52490972‑52548742) (GRCh37) from partial exon2‑ exon21 to external ATP7B sequence (15.833bp) in the patient. Analysis of the family members of the patient showed that the missense mutation and the gross deletion mutation were inherited from her mother and father, respectively. Microhomology and inverted repeat sequences, which may mediate the deletion mutation, were identified through sequence analysis on both sides of the breakpoints of this deletion. The present study provided additional information on the genotypic spectrum of the ATP7B gene, particularly with regard to early onset hepatic disease, as observed in the present patient with WD. The identification of the precise breakpoint junction sequence warrants further investigation of DNA break and recombination mechanisms. In detecting precise deletions, the NGS associated with Sanger sequencing of breakpoint junction sequence have been found to have more advantages than MLPA.

View Figures

View References

1	Danks DM: Disorders of copper transport. The metabolic basis of inherited diseases. Scriver CR, Beaudet AL, Sly WS and Valle D: 1. 6th. McGraw-Hill; New York, NY: pp. 1416–1422. 1989
2	Scheinberg IH and Sternlieb I: Wilson disease. Major Problems in Internal Medicine. Lloyd H and Smith J: Saunders; Philadelphia, PA: 1984
3	Sternlieb I: Perspectives on Wilson's disease. Hepatology. 12:1234–1239. 1990. View Article : Google Scholar : PubMed/NCBI
4	Petrukhin K, Fischer SG, Pirastu M, Tanzi RE, Chernov I, Devoto M, Brzustowicz LM, Cayanis E, Vitale E and Russo JJ: Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nat Genet. 5:338–343. 1993. View Article : Google Scholar : PubMed/NCBI
5	Terada K, Schilsky ML, Miura N and Sugiyama T: ATP7B (WND) protein. Int J Biochem Cell Biol. 30:1063–1067. 1998. View Article : Google Scholar : PubMed/NCBI
6	Thomas GR, Forbes JR, Roberts EA, Walshe JM and Cox DW: The Wilson disease gene: Spectrum of mutations and their consequences. Nat. Genet. 9:210–217. 1995. View Article : Google Scholar : PubMed/NCBI
7	Piekarski J, Goldberg HI, Royal SA, Axel L and Moss AA: Difference between liver and spleen CT numbers in the normal adult: Its usefulness in predicting the presence of diffuse liver disease. Radiology. 137:727–729. 1980. View Article : Google Scholar : PubMed/NCBI
8	Loudianos G, Dessì V, Lovicu M, Angius A, Nurchi A, Sturniolo GC, Marcellini M, Zancan L, Bragetti P, Akar N, et al: Further delineation of the molecular pathology of wilson disease in the mediterranean population. Hum Mutat. 12:89–94. 1998. View Article : Google Scholar : PubMed/NCBI
9	Subramanian I, Vanek ZF and Bronstein JM: Diagnosis and treatment of Wilson's disease. Curr Neurol Neurosci Rep. 2:317–323. 2002. View Article : Google Scholar : PubMed/NCBI
10	Medici V, Rossaro L and Sturniolo GC: Wilson disease-A practical approach to diagnosis, treatment and follow-up. Dig Liver Dis. 39:601–609. 2007. View Article : Google Scholar : PubMed/NCBI
11	Das SK and Ray K: Wilson's disease: An update. Nat Clin Pract Neurol. 2:482–493. 2006. View Article : Google Scholar : PubMed/NCBI
12	Brewer GJ and Askari FK: Wilson's disease: Clinical management and therapy. J Hepatol. 42 (Suppl):S13–S21. 2005. View Article : Google Scholar : PubMed/NCBI
13	Hedera P: Update on the clinical management of Wilson's disease. Appl Clin Genet. 10:9–19. 2017. View Article : Google Scholar : PubMed/NCBI
14	Mak CM and Lam CW: Diagnosis of Wilson's disease: A comprehensive review. Crit Rev Clin Lab Sci. 45:263–290. 2008. View Article : Google Scholar : PubMed/NCBI
15	Dalvi A and Padmanaban M: Wilson's disease: Etiology, diagnosis, and treatment. Dis Mon. 60:450–459. 2014. View Article : Google Scholar : PubMed/NCBI
16	Ferenci P: Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: Impact on genetic testing. Hum Genet. 120:151–159. 2006. View Article : Google Scholar : PubMed/NCBI
17	Shah AB, Chernov I, Zhang HT, Ross BM, Das K, Lutsenko S, Parano E, Pavone L, Evgrafov O, Ivanova-Smolenskaya IA, et al: Identification and analysis of mutations in the Wilson disease gene (ATP7B): Population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Genet. 61:317–328. 1997. View Article : Google Scholar : PubMed/NCBI
18	Liu XQ, Zhang YF, Liu TT, Hsiao KJ, Zhang JM, Gu XF, Bao KR, Yu LH and Wang MX: Correlation of ATP7B genotype with phenotype in Chinese patients with Wilson disease. World J Gastroenterol. 10:590–593. 2004. View Article : Google Scholar : PubMed/NCBI
19	Kim EK, Yoo OJ, Song KY, Yoo HW, Choi SY, Cho SW and Hahn SH: Identification of three novel mutations and a high frequency of the Arg778Leu mutation in Korean patients with Wilson disease. Hum Mutat. 11:275–278. 1998. View Article : Google Scholar : PubMed/NCBI
20	Okada T, Shiono Y, Hayashi H, Satoh H, Sawada T, Suzuki A, Takeda Y, Yano M, Michitaka K, Onji M and Mabuchi H: Mutational analysis of ATP7B and genotype-phenotype correlation in Japanese with Wilson's disease. Hum Mutat. 15:454–462. 2000. View Article : Google Scholar : PubMed/NCBI
21	Incollu S, Lepori MB, Zappu A, Dessì V, Noli MC, Mameli E, Iorio R, Rannuci G, Cao A and Loudianos G: DNA and RNA studies for molecular characterization of a gross deletion detected in homozygosity intheNH2-terminal region of the ATP7B gene in a Wilson disease patient. Mol Cell Probes. 25:195–198. 2011. View Article : Google Scholar : PubMed/NCBI
22	Tatsumi Y, Shinohara T, Imoto M, Wakusawa S, Yano M, Hayashi K, Hattori A, Hayashi H, Shimizu A, Ichiki T, et al: Potential of the international scoring system for the diagnosis of Wilson disease to differentiate Japanese patients who need anti-copper treatment. Hepatol Res. 41:887–896. 2011. View Article : Google Scholar : PubMed/NCBI
23	Møller LB, Ott P, Lund C and Horn N: Homozygosity for a gross partial gene deletion of the C-terminal end of ATP7B in a Wilson patient with hepatic and no neurological manifestations. Am J Med Genet A. 138:340–343. 2005. View Article : Google Scholar : PubMed/NCBI
24	Todorov T, Balakrishnan P, Savov A, Socha P and Schmidt HH: Intragenic deletions in ATP7B as an unusual molecular genetics mechanism of Wilson's disease pathogenesis. PLoS One. 11:e01683722016. View Article : Google Scholar : PubMed/NCBI
25	Liu G, Ma D, Cheng J, Zhang J, Luo C, Sun Y, Hu P, Wang Y, Jiang T and Xu Z: Identification and characterization of a novel 43-bp deletion mutation of the ATP7B gene in a Chinese patient with Wilson's disease: A case report. BMC Med Genet. 19:612018. View Article : Google Scholar : PubMed/NCBI
26	Chen YC, Yu H, Wang RM, Xie JJ, Ni W, Zhang Y, Dong Y and Wu ZY: Contribution of intragenic deletions to mutation spectrum in Chinese patients with Wilson's disease and possible mechanism underlying ATP7B gross deletions. Parkinsonism Relat Disord. 62:128–133. 2019. View Article : Google Scholar : PubMed/NCBI
27	Mameli E, Lepori MB, Chiappe F, Ranucci G, Di Dato F, Iorio R and Loudianos G: Wilson's disease caused by alternative splicing and Alu exonization due to a homozygous 3039-bp deletion spanning from intron 1 to exon 2 of the ATP7B gene. Gene. 569:276–279. 2015. View Article : Google Scholar : PubMed/NCBI